Profile | GDS5420 / 243511_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 176.19 | 50 |
GSM1296119 | B_lesional_pre-dose | 110.36 | 42 |
GSM1296076 | C_lesional_pre-dose | 60.73 | 34 |
GSM1296092 | D_lesional_pre-dose | 53.45 | 34 |
GSM1296103 | E_lesional_pre-dose | 140.96 | 47 |
GSM1296078 | F_lesional_pre-dose | 68.34 | 36 |
GSM1296107 | G_lesional_pre-dose | 130.84 | 44 |
GSM1296109 | H_lesional_pre-dose | 132.24 | 44 |
GSM1296080 | I_lesional_pre-dose | 192.86 | 53 |
GSM1296090 | J_lesional_pre-dose | 68.89 | 37 |
GSM1296074 | K_lesional_pre-dose | 68.06 | 38 |
GSM1296111 | L_lesional_pre-dose | 139.09 | 45 |
GSM1296099 | M_lesional_pre-dose | 180.55 | 50 |
GSM1296086 | O_lesional_pre-dose | 82.3 | 40 |
GSM1296117 | P_lesional_pre-dose | 136.87 | 45 |
GSM1296113 | Q_lesional_pre-dose | 98.08 | 37 |
GSM1296096 | R_lesional_pre-dose | 162.91 | 49 |
GSM1296105 | S_lesional_pre-dose | 190.37 | 51 |
GSM1296098 | T_lesional_pre-dose | 266.78 | 57 |
GSM1296101 | U_lesional_pre-dose | 172.59 | 49 |
GSM1296121 | V_lesional_pre-dose | 88.72 | 38 |
GSM1296088 | W_lesional_pre-dose | 74.81 | 38 |
GSM1296082 | X_lesional_pre-dose | 74.25 | 39 |
GSM1296115 | Y_lesional_pre-dose | 146.58 | 47 |
GSM1296084 | Z_lesional_pre-dose | 235.3 | 55 |
GSM1296072 | B_lesional_day8 | 164.38 | 48 |
GSM1296069 | L_lesional_day8 | 146.97 | 45 |
GSM1296071 | P_lesional_day8 | 171.96 | 47 |
GSM1296070 | Y_lesional_day8 | 143.67 | 45 |
GSM1296073 | V_lesional_day8 | 73.91 | 36 |
GSM1296034 | A_lesional_day15 | 249.4 | 55 |
GSM1296041 | G_lesional_day15 | 116.89 | 43 |
GSM1296035 | R_lesional_day15 | 105.01 | 43 |
GSM1296038 | U_lesional_day15 | 182.34 | 51 |
GSM1296047 | B_lesional_day15 | 196.69 | 51 |
GSM1296039 | E_lesional_day15 | 124.94 | 45 |
GSM1296042 | H_lesional_day15 | 126.7 | 43 |
GSM1296043 | L_lesional_day15 | 154.52 | 46 |
GSM1296037 | M_lesional_day15 | 120.38 | 43 |
GSM1296046 | P_lesional_day15 | 176.89 | 48 |
GSM1296044 | Q_lesional_day15 | 145.16 | 45 |
GSM1296045 | Y_lesional_day15 | 137.41 | 44 |
GSM1296025 | C_lesional_day15 | 235.21 | 56 |
GSM1296033 | D_lesional_day15 | 120.65 | 45 |
GSM1296027 | I_lesional_day15 | 170.9 | 51 |
GSM1296032 | J_lesional_day15 | 130.7 | 45 |
GSM1296024 | K_lesional_day15 | 301.86 | 60 |
GSM1296031 | W_lesional_day15 | 147.85 | 47 |
GSM1296028 | X_lesional_day15 | 137.81 | 47 |
GSM1296029 | Z_lesional_day15 | 150.82 | 48 |
GSM1296026 | F_lesional_day15 | 145.09 | 48 |
GSM1296030 | O_lesional_day15 | 112.79 | 46 |
GSM1296040 | S_lesional_day15 | 171.11 | 49 |
GSM1296036 | T_lesional_day15 | 252.54 | 55 |
GSM1296048 | V_lesional_day15 | 107.73 | 41 |
GSM1296059 | A_lesional_day43 | 97.42 | 42 |
GSM1296066 | G_lesional_day43 | 129.94 | 44 |
GSM1296060 | R_lesional_day43 | 196.42 | 52 |
GSM1296063 | U_lesional_day43 | 136.33 | 46 |
GSM1296064 | E_lesional_day43 | 141.71 | 48 |
GSM1296067 | H_lesional_day43 | 208.18 | 51 |
GSM1296062 | M_lesional_day43 | 160.31 | 49 |
GSM1296068 | Q_lesional_day43 | 156.58 | 46 |
GSM1296050 | C_lesional_day43 | 176.5 | 50 |
GSM1296057 | D_lesional_day43 | 252.6 | 56 |
GSM1296052 | I_lesional_day43 | 136.51 | 48 |
GSM1296054 | J_lesional_day43 | 185.07 | 50 |
GSM1296049 | K_lesional_day43 | 156.95 | 49 |
GSM1296055 | W_lesional_day43 | 138.53 | 45 |
GSM1296053 | X_lesional_day43 | 151.1 | 48 |
GSM1296058 | Z_lesional_day43 | 202.72 | 53 |
GSM1296051 | F_lesional_day43 | 88.07 | 40 |
GSM1296056 | O_lesional_day43 | 103.83 | 43 |
GSM1296065 | S_lesional_day43 | 133.91 | 45 |
GSM1296061 | T_lesional_day43 | 209.66 | 53 |
GSM1296095 | A_non-lesional_pre-dose | 137.34 | 47 |
GSM1296120 | B_non-lesional_pre-dose | 124.38 | 43 |
GSM1296077 | C_non-lesional_pre-dose | 145.35 | 48 |
GSM1296093 | D_non-lesional_pre-dose | 135.05 | 45 |
GSM1296104 | E_non-lesional_pre-dose | 121.83 | 44 |
GSM1296079 | F_non-lesional_pre-dose | 171.71 | 51 |
GSM1296108 | G_non-lesional_pre-dose | 132.46 | 44 |
GSM1296110 | H_non-lesional_pre-dose | 133.74 | 43 |
GSM1296081 | I_non-lesional_pre-dose | 90.65 | 41 |
GSM1296091 | J_non-lesional_pre-dose | 63.41 | 35 |
GSM1296075 | K_non-lesional_pre-dose | 125.75 | 46 |
GSM1296112 | L_non-lesional_pre-dose | 187.26 | 49 |
GSM1296100 | M_non-lesional_pre-dose | 159.91 | 48 |
GSM1296087 | O_non-lesional_pre-dose | 114.18 | 46 |
GSM1296118 | P_non-lesional_pre-dose | 173.35 | 48 |
GSM1296114 | Q_non-lesional_pre-dose | 139.77 | 44 |
GSM1296097 | R_non-lesional_pre-dose | 245.34 | 56 |
GSM1296106 | S_non-lesional_pre-dose | 155.5 | 47 |
GSM1296102 | U_non-lesional_pre-dose | 261.05 | 55 |
GSM1296122 | V_non-lesional_pre-dose | 162.68 | 48 |
GSM1296089 | W_non-lesional_pre-dose | 115.45 | 42 |
GSM1296083 | X_non-lesional_pre-dose | 160.34 | 49 |
GSM1296116 | Y_non-lesional_pre-dose | 129.12 | 42 |
GSM1296085 | Z_non-lesional_pre-dose | 239.28 | 55 |